Clinical trial
Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
NCT00176800 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00176800 |
|---|---|
| Title | Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma |
| Official title | Pre-Operative Chemoradiation Followed by Post-Operative Tetrathiomolybdate (TM) in Patients With Loco-Regional Esophageal Carcinoma (UMCC 2001-007) |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Carcinoma |
| Intervention type | Drug, Procedure |
| Interventions | Tetrathiomolybdate (TM), Radiation, Surgery |
| Enrollment | 69 |
| Start date | Nov 1, 2001 |
| Primary completion | Feb 1, 2006 |
| Completion | May 1, 2013 |
| First posted | Sep 15, 2005 |
| Last update posted | Aug 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: